A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: sandimmune and neoral

By Shah M.B.   Martin J.E.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4048-4053

Elsevier

Access to resources Recommend Favorite

Validity of open labeled versus blinded trials: a meta-analysis comparing neoral and sandimmune

By Shah M.B.   Martin J.E.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 217-219

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients

By Gaston R.   Alloway R.R.   Gaber A.O.   Rossi S.J.   Schroeder T.J.   Irish W.D.   Canafax D.M.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 326-327

Elsevier

Access to resources Recommend Favorite

Safety of conversion from cyclosporine sandimmune to cyclosporine neoral in stable liver transplant patients

By Baruch Y.   Assy N.   Kramsky R.   Enat R.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1852-1853

Elsevier

Access to resources Recommend Favorite

Neoral versus sandimmune in kidney transplantation

By Tisone G.   Orlando G.   Mercadante E.   Vennarecci G.   Pisani F.   Buonomo O.   Negrini S.   Casciani C.U.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1749-1750

Elsevier

Access to resources Recommend Favorite